Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.42 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.42 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.42 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.42 |
| ▸ | P2RY14 | Q15391 | 7/20 | 0.37 |
| ▸ | PYGB | P11216 | 3/20 | 0.36 |
| ▸ | PYGL | P06737 | 2/20 | 0.36 |
| ▸ | PYGM | P11217 | 1/20 | 0.36 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.35 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.33 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL28043634 | 0.99 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| Taurine SCHEMBL28119150 | 0.88 | SLC28A1 (0.35) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL29280336 | 0.87 | SLC28A1 (0.34) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL42133 | 0.87 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL12658269 | 0.87 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL6002015 | 0.87 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| Hydrogen Sulfide SCHEMBL28043850 | 0.86 | SLC28A1 (0.49) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| Ammonia Solution, Strong SCHEMBL28145131 | 0.86 | SLC28A1 (0.49) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL29824657 | 0.84 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL28996776 | 0.84 | SLC28A1 (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120092014-A | RNA constructs and uses thereof | 生物技术欧洲股份公司 | 2025-06-03 | — | — | CN | claimed |
| CN-117866948-B | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118660973-A | RNA and DNA analysis Using engineered surfaces | 阿丽达生物科学公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118613500-A | Modified mRNA treatment | 沙塔克实验室有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-118176209-A | Treatment involving non-immunogenic RNA and PD-1 axis binding antagonists for antigen vaccination | 生物技术公司 | 2024-06-11 | — | — | CN | claimed |
| CN-118161602-A | RNA for treating autoimmune diseases | 生物技术公司 | 2024-06-11 | — | — | CN | claimed |
| CN-117915945-A | Novel proteins and nucleic acid sequences for COVID-19 vaccines | 东佩制药股份公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117750971-A | Methods of treating or preventing autoimmune diseases | 易姆赛斯股份公司 | 2024-03-22 | — | — | CN | claimed |
| CN-115461509-B | Sulfuric acid composition and use thereof | 六环股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117413065-A | Constructs, methods and uses for the preparation of circular RNAs | 上海环码生物医药有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-111744019-B | Mannose-based mRNA targeted delivery system and application thereof | 深圳瑞吉生物科技有限公司 | 2023-08-04 | — | — | CN | claimed |
| WO-2022000884-A1 | MANNOSE-BASED MRNA TARGETED DELIVERY SYSTEM AND USE THEREOF | 深圳市瑞吉生物科技有限公司 | 2022-01-06 | — | — | WO | claimed |
| CN-113396219-B | Purification of mRNA by tangential flow filtration | ETHRIS GMBH (DE) | 2026-05-26 | — | — | CN | disclosed |
| WO-2026103936-A1 | CHEMICALLY MODIFIED CIRCULAR RNA MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海元码智药生物技术有限公司 | 2026-05-21 | — | — | WO | disclosed |
| CN-122070137-A | Method of | 百欧恩泰欧洲股份公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122070365-A | Systems and compositions comprising highly active trans-amplified replicase | 百欧恩泰欧洲股份公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2002083725-A1 | NOVEL STRESS PROTEIN WITH CHAPERONE ACTIVITY | RNA INC. (KR) | 2002-10-24 | — | — | WO | disclosed |
| EP-0549615-A4 | SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION | ISIS PHARMACEUTICALS INC (US) | 1997-08-27 | — | — | EP | disclosed |
| EP-0549615-A1 | SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| WO-1992003568-A1 | SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1992-03-05 | — | — | WO | disclosed |